Expression of Na+-K+-2Cl- cotransporter isoform 1 (NKCC1) predicts poor prognosis in lung adenocarcinoma and EGFR-mutated adenocarcinoma patients.

Explore this paper's citation graph

Summary

NKCC1 high expression predicted a bad clinical outcome for lung adenocarcinoma patients andEGFR-mutated subgroup and novel therapeutic tactics could be developed by targeting NKCC1 protein.

Type
article
Published
2016-04-01
Cited by
22
References
35
Access
Open access

Keywords

Adenocarcinoma, Internal medicine, Medicine, Immunohistochemistry, Perineural invasion

References

Cited by

Related papers